301 - Evaluation of a Student-Tailored Version of the National Diabetes Prevention Program: A Randomized Pilot Trial among Vulnerable Undergraduates
Sunday, April 27, 2025
8:30am – 10:45am HST
Lauren E. Wisk, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA, United States; Kate Diaz Roldan, University of California, Los Angeles David Geffen School of Medicine, Covina, CA, United States; Angelique Rubio, UCLA, Highland, CA, United States; Nicholas Jackson, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA, United States; Juliet Cushing, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA, United States; Valerie Kryger, University of California, Los Angeles David Geffen School of Medicine, Alhambra, CA, United States; Samantha Soetenga, UCLA Recreation, Los Angeles, CA, United States; Tannaz Moin, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA, United States